Rhesus Haemolytic Disease Flashcards
What is the difference between isoimmunisation and alloimmunisation?
Isoimmunisation
maternal antibodies develop against fetal red blood cells. These cross to the fetus and my lead to haemolysis (and associated complications).
Alloimmunisation
IM injection of anti-D, provides passive immunisation of a non-sensitised woman around the time of exposure to RhD. Prevents isoimmunisation.
What is the pathophysiology of Rhesus Haemolytic Disease?
- Child has Rh+ blood type (heterozygous due to paternal genes), while mother is Rh+.
- Fetal-maternal haemorrhage.
- Generation of IgM antibodies on first exposure.
- On further exposure of fetal blood cells (2nd pregnancy) - IgG antibodies formed. Cross the placenta and cause hemolysis of the fetal RBC, causing fetal anemia and further complications (see other flashcards/OneNote).
What are the possible causes of fetomaternal haemorrhage?
- labor
- antepartum haemorrhage
- external cephalic version
- trauma (ie, mva)
- amniocentesis/cvs
- miscarriage
- ectopic pregnancy
- miscarriage
- partial molar pregnancy
- silent f-m haemorrhage
What are the effects of fetal hemolysis (due to antibody attack) on the fetus
ANEMIA: –>
Liver
- portal HTN
- hepatosplenomegaly.
Circulatory
- Hyperdynamic circulation
- CCF
- cardiac compromise
- hypoviscosity
Tissues
- tissue hypoxia
- increased brain perfusion
- hydrops fetalis (sometimes assoc with polyhydramnios)
FDIU!!
What signs do you look for to identify fetal anemia - seen on MCA doppler, CTG and US
MCA Doppler:
- hyperdynamic circulation (Increased HR)
= increased peak velocity
reliable < 34 weeks
US
- hydrops fetalis (ascites, pericardial effusion) + polyhydramnios
- enlarged fetal heart
CTG
- reduced movements
- increased HR
- abnormal: reduced variability, sinusoidal trace)
What investigations are carried out antenatally to prevent hemolytic disease?
First antenatal test (19-20 weeks): Blood group and antibody screen (G+S).
If Rh+ - nothing.
If Rh- :
- further G+S at 28 weeks + 34 weeks.
- IgG antibodies at 28 + 34 weeks.
Consider
- Fetal surveillance (US, CTG, MCA doppler)
- Paternal blood type (gives idea of likelihood of baby’s blood type)
- Cord sampling (Kleihauer test - if further antibodies needed).
- NIPT: to determine blood type of baby.
What is the management if an elevated MCA flow or amniotic biliruben levels are found to be high?
Intravascular intrauterine blood transfusion.
If very serious (hydrops etc ) - deliver at 28 weeks.
What is the prognosis, in hydrops fetalis vs non hydrops fetalis?
If no hydrops - fetuses undergoing IUT >90%,
If hydrops - 75% survival.